Experienced in Schizoaffective Disorder

Dr. Vrijendra K. Hoon

Internal Medicine
3450 N Buffalo Dr, 
Las Vegas, NV 
Experienced in Schizoaffective Disorder
3450 N Buffalo Dr, 
Las Vegas, NV 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vrijendra Hoon is a primary care provider, practicing in Internal Medicine in Las Vegas, Nevada. Dr. Hoon is rated as an Experienced provider by MediFind in the treatment of Schizoaffective Disorder. His top areas of expertise are Dehydration, Schizoaffective Disorder, Asthma in Children, and Asthma.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in NV
Hospital Affiliations
Mountainview Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 4 Less Insurance Carriers -

Locations

3450 N Buffalo Dr, Las Vegas, NV 89129

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials
Similar Doctors
Advanced in Schizoaffective Disorder
Dr. Naser K. Hakki
Internal Medicine
Advanced in Schizoaffective Disorder
Dr. Naser K. Hakki
Internal Medicine

University Medical Center Of Southern Nevada

1800 W Charleston Blvd, 
Las Vegas, NV 
 (6.7 miles away)
702-383-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Naser Hakki is a primary care provider, practicing in Internal Medicine in Las Vegas, Nevada. Dr. Hakki is rated as an Advanced provider by MediFind in the treatment of Schizoaffective Disorder. His top areas of expertise are Schizoaffective Disorder, Stroke, Sepsis, Gastrostomy, and Endoscopy. Dr. Hakki is currently accepting new patients.

Advanced in Schizoaffective Disorder
Dr. Andrew E. Morrison
Internal Medicine | Emergency Medicine
Advanced in Schizoaffective Disorder
Dr. Andrew E. Morrison
Internal Medicine | Emergency Medicine

Superior Emergency Physicians Harris PLLC

1409 E Lake Mead Blvd, 
North Las Vegas, NV 
 (7.9 miles away)
702-649-7711
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Morrison is an Emergency Medicine provider in North Las Vegas, Nevada. Dr. Morrison is rated as an Advanced provider by MediFind in the treatment of Schizoaffective Disorder. His top areas of expertise are Cannabinoid Hyperemesis Syndrome (CHS), Inappropriate Sinus Tachycardia (IST), Schizoaffective Disorder, and Muscle Spasms. Dr. Morrison is currently accepting new patients.

Advanced in Schizoaffective Disorder
Dr. Pavan K. Janapati
Internal Medicine
Advanced in Schizoaffective Disorder
Dr. Pavan K. Janapati
Internal Medicine

Nevada Post-Acute Medical Services-Scherr 1 P.C

8550 S Eastern Ave, 
Las Vegas, NV 
 (15.3 miles away)
702-382-3155
Languages Spoken:
English
See accepted insurances

Pavan Janapati is a primary care provider, practicing in Internal Medicine in Las Vegas, Nevada. Dr. Janapati is rated as a Distinguished provider by MediFind in the treatment of Schizoaffective Disorder. His top areas of expertise are Cellulitis, Dementia, Osteomyelitis in Children, Anemia, and Gastrostomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hoon's expertise for a condition
ConditionClose
      View All 28 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile